Your browser doesn't support javascript.
loading
Reaching for 90:90:90 in Correctional Facilities in South Africa and Zambia: Virtual Cross-Section of Coverage of HIV Testing and Antiretroviral Therapy During Universal Test and Treat Implementation.
Hoffmann, Christopher J; Herce, Michael E; Chimoyi, Lucy; Smith, Helene J; Tlali, Mpho; Olivier, Cobus J; Topp, Stephanie M; Muyoyeta, Monde; Reid, Stewart E; Hausler, Harry; Charalambous, Salome; Fielding, Katherine.
Afiliação
  • Hoffmann CJ; Department of Medicine, Johns Hopkins University, Baltimore, MD.
  • Herce ME; The Aurum Institute, Johannesburg, South Africa.
  • Chimoyi L; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
  • Smith HJ; Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC.
  • Tlali M; The Aurum Institute, Johannesburg, South Africa.
  • Olivier CJ; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
  • Topp SM; School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
  • Muyoyeta M; TB HIV Care, Cape Town, South Africa.
  • Reid SE; College of Public Health Medicine and Veterinary Sciences, James Cook University, Townsville, Australia.
  • Hausler H; Nossal Institute for Global Health, University of Melbourne, Melbourne, Australia.
  • Charalambous S; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
  • Fielding K; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
J Acquir Immune Defic Syndr ; 96(5): 465-471, 2024 08 15.
Article em En | MEDLINE | ID: mdl-38985444
ABSTRACT

BACKGROUND:

People in correctional settings are a key population for HIV epidemic control. We sought to demonstrate scale-up of universal test and treat in correctional facilities in South Africa and Zambia through a virtual cross-sectional analysis.

METHODS:

We used routine data on 2 dates At the start of universal test and treat implementation (time 1, T1) and 1 year later (time 2, T2). We obtained correctional facility census lists for the selected dates and matched HIV testing and treatment data to generate virtual cross-sections of HIV care continuum indicators.

RESULTS:

In the South African site, there were 4193 and 3868 people in the facility at times T1 and T2; 43% and 36% were matched with HIV testing or treatment data, respectively. At T1 and T2, respectively, 1803 (43%) and 1386 (36%) had known HIV status, 804 (19%) and 845 (21%) were known to be living with HIV, and 60% and 56% of those with known HIV were receiving antiretroviral therapy (ART). In the Zambian site, there were 1467 and 1366 people in the facility at times T1 and T2; 58% and 92% were matched with HIV testing or treatment data, respectively. At T1 and T2, respectively, 857 (59%) and 1263 (92%) had known HIV status, 277 (19%) and 647 (47%) were known to be living with HIV, and 68% and 68% of those with known HIV were receiving ART.

CONCLUSIONS:

This virtual cross-sectional analysis identified gaps in HIV testing coverage, and ART initiation that was not clearly demonstrated by prior cohort-based studies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Teste de HIV Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Teste de HIV Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article